NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

MAKO, a national reference laboratory based in Raleigh, has validated a PCR-based monkeypox-specific research assay developed by Thermo Fisher Scientific.
Burlington-based Labcorp will begin offering a diagnostic test for the monkeypox virus, and Bavarian Nordic, a Danish company with a U.S. subsidiary in Morrisville, will provide the only monkeypox vaccine approved by the FDA.
Durham-based Deep Blue Medical Advances has raised more than $7 million in venture capital to commercialize a device for repairing hernias.
North Carolina’s Research Triangle region is the nation’s fourth leading hub for biotechnology activity, trailing only Boston, San Francisco and San Diego, says Fierce Biotech, an online publication that covers the biotechnology and pharmaceutical industries.
Cary-based Atom Bioworks (Atombio) has been selected as one of 14 promising global life-sciences startups to participate in the BioTools Innovator Accelerator program.
The BioNetwork Learning Solutions Center and Gaston College, just west of Charlotte, will host a virtual summer career fair for BioWork, life science degree and BioNetwork students and job seekers on Wednesday, August 3, from 3 to 6 p.m.
Morrisville-headquartered biotechnology startup Inceptor Bio has inked a deal with the University of Minnesota to create a new cell-based tool to fight difficult-to-treat cancers.
Anthony Atala, M.D., told a Triad BioNight crowd of nearly 400 that WFIRM’s scientists, technicians and physicians are working on regenerative medicine therapies for about 40 different organs and tissues, building on 15 applications that have been used in patients to date.
Winston-Salem-based Plakous Therapeutics has won the 2022 NC BIONEER Venture Challenge. The announcement was made at Triad BioNight.
Here are the winners of Excellence Awards at Triad BioNight, a celebration of the region’s life sciences community organized by the Piedmont Triad Office of the North Carolina Biotechnology Center.
Durham-based Precision Biosciences’ genome editing technology has drawn interest – and investment – from another global pharmaceutical giant. This time it’s Novartis.
Novozymes and Biotalys are partnering on developing the market for Biotalys’ new environmentally friendly biofungicide, Evoca,
Guy Aday was the operations chief for the U.S. Consulate in Northern Afghanistan. After he injured his back and returned to the U.S. for back surgery and physical and vocational rehabilitation, he found a rewarding new career path in biotech via Alamance Community College.
The Foundation Fighting Blindness (FFB), with a spinoff startup headquartered in the Raleigh, is changing its executive leadership team.
The North Carolina Biotechnology Center awarded 18 grants and loans totaling $1,755,181 to universities, bioscience companies and nonprofit organizations in the third quarter of its fiscal year.
scroll back to top of page